ImmunoPrecise is headquartered in Victoria, British Columbia.
ImmunoPrecise disclosed revenue of 25M CAD for 2025 and 25M CAD for 2024.
ImmunoPrecise has 102 employees.
ImmunoPrecise is a life science company.
ImmunoPrecise was founded in 1983.
3204–4464 Markham Street,
Victoria, British Columbia
V8Z 7X8
Canada,
(250) 483-0308
www.ipatherapeutics.com
ImmunoPrecise is a full-service, therapeutic antibody discovery company focused on the next generation of antibody discovery, to deliver the most therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials. ImmunoPrecise was founded in 1983 and is based in Victoria, Canada.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.4/yr) | # | 1 | - | 1 | - | 1 | - | 3 |
| vol | $570K | $23M | $23M | |||||
| Sell (0.2/yr) | # | - | - | - | - | - | 1 | 1 |
| vol | $12M | $12M | ||||||
| 4 | ||||||||
| Financial | Deals |
|---|---|
|
Edgemont Capital Partners |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
